Press release - 04/12/2024 Joint research in key technologies: NMI and KIT sign cooperation agreement The NMI Natural and Medical Sciences Institute and the Karlsruhe Institute of Technology (KIT) have signed a groundbreaking cooperation agreement. This partnership combines the expertise of both institutions in the fields of production and characterization of materials for biological systems and energy storage as well as the application of statistical methods in medicine.https://www.gesundheitsindustrie-bw.de/en/article/press-release/joint-research-key-technologies-nmi-and-kit-sign-cooperation-agreement
Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB - 24/04/2020 A rapid pyrogen test: the human immune system as model Every year, around 11 million people die of sepsis (blood poisoning) caused by microorganisms or microbial residues, known as pyrogens, entering the bloodstream. The smallest amounts can trigger fever. Researchers from the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart have developed a pyrogen test that does not require a laboratory and is not tested on animals. It is expected to be placed on the market soon.https://www.gesundheitsindustrie-bw.de/en/article/news/A-rapid-pyrogen-test-the-human-immune-system-as-model
Biochip systems - 02/09/2020 Miniature organs with great potential Dr. Peter Loskill and his team at the Fraunhofer Institute in Stuttgart and the University Hospital of Tübingen are developing what is known as an "organ-on-a-chip" (OoC). An OoC is a microfluidic system that simulates small functional units of organ tissue. OoCs can be used in different ways: in basic and pharmaceutical research as well as in clinical research and application, where they might render many animal experiments…https://www.gesundheitsindustrie-bw.de/en/article/news/miniature-organs-great-potential
Neurosciences - 28/02/2024 Mesh microelectrode arrays: research with brain organoids on a new level How does the brain work? Brain organoids are derived from pluripotent stem cells and regarded as valuable model systems that can depict some aspects of neurological functioning. Dr. Peter Jones from NMI together with Dr. Thomas Rauen from the MPI for Molecular Biomedicine in Münster, has taken organoid research to a new level. His novel mesh microelectrode array (Mesh-MEA) greatly improves the growth and electrophysiological analysis of tissue.https://www.gesundheitsindustrie-bw.de/en/article/news/mesh-microelectrode-arrays-research-brain-organoids-new-level
3R-Center - 18/08/2021 Putting alternatives to animal testing into practice Animal experiments are still central to biomedical research. However, it has become increasingly clear that not all of them are absolutely necessary. Alternative techniques exist. The new 3R-Netzwerk Baden-Württemberg is now seeking to promote these more vigorously - and improve animal welfare in cases where alternatives to animal testing are not available.https://www.gesundheitsindustrie-bw.de/en/article/news/putting-alternatives-animal-testing-practice
Dossier: Innovative animal-free research in Baden-Württemberg - 05/12/2024 Mini-organs and multi-organ chips - where lab mice may soon retire Farewell to animal testing? Life sciences researchers in BW are pioneering innovative methods to replace animal experiments, reduce the number of animals used and refine the procedures and conditions under which animals are kept. These are the guiding principles of the 3Rs principle. Developing cutting-edge models and establishing a robust 3R network, not only shapes the future of research but also improves the quality of scientific outcomes.https://www.gesundheitsindustrie-bw.de/en/article/dossier/mini-organs-and-multi-organ-chips-where-lab-mice-may-soon-retire
Funding Innovation Prize of the German BioRegions 2025 Competition, Funded by: BIO Deutschland e. V., sb_search.searchresult.label.programSubmissionDate: 14/02/2025 https://www.gesundheitsindustrie-bw.de/en/database/funding/innovationspreis-der-bioregionen-deutschlands-2025
Event - 24/05/2025 - 25/05/2025 Sahlgrenska Global Health Hackathon Göttingen, Registration deadline: 24/12/2024, Hackathon https://www.gesundheitsindustrie-bw.de/en/event/sahlgrenska-global-health-hackathon
Transcranial magnetic stimulation (TMS) - 10/12/2024 sync2brain: using magnetic waves to combat depression In cases where standard therapies for mental illnesses such as depression prove ineffective, transcranial magnetic stimulation (TMS) offers a promising alternative. This method uses magnetic pulses to stimulate specific regions of the brain. The company sync2brain has developed a system that leverages EEG measurements to tailor stimulation to each patient's unique brain wave patterns, that may significantly enhance the therapy's…https://www.gesundheitsindustrie-bw.de/en/article/news/sync2brain-using-magnetic-waves-combat-depression
Save the date - 28/11/2024 Meet & Match - Gender Medicine: Biological insights and healthcare advances Strasbourg (France) | CIARUS, Registration deadline: 27/11/2024, Meet & Match https://www.gesundheitsindustrie-bw.de/en/event/meet-und-match-gender-medicine-biological-insights-and-healthcare-advances
NMI spin-off develops theranostics - 02/12/2024 immuneAdvice develops diagnostics to predict the efficacy of immunotherapies Certain types of cancer are already being effectively treated using immunotherapies, though success rates can vary significantly between patients. Researchers from the Natural and Medical Sciences Institute (NMI) in Reutlingen, along with colleagues at the University of Tübingen, are working on a diagnostic approach to accompany therapy, which would rapidly assess whether the treatment is effective or requires adjustment. https://www.gesundheitsindustrie-bw.de/en/article/news/immuneadvice-develops-diagnostics-predict-efficacy-immunotherapies
Event - 14/01/2025 RehAllianCE Transnational Pilot Action - Call application online seminar Online, Online seminar https://www.gesundheitsindustrie-bw.de/en/event/rehalliance-transnational-pilot-action-call-application-online-seminar
Press release - 13/12/2024 Schizophrenia: NMI observes processes in nerve cells Up to now, schizophrenia has mainly been treated symptomatically, as little is known about the exact underlying processes. Researchers at the NMI Natural and Medical Sciences Institute in Reutlingen have succeeded in gaining a better understanding of the driving mechanisms of the disease. This offers opportunities for the development of new drugs. They have published their findings in the journal BMC Psychiatry.https://www.gesundheitsindustrie-bw.de/en/article/press-release/schizophrenia-nmi-observes-processes-nerve-cells
Press release - 11/12/2024 Top German research prize goes to Freiburg cancer researcher The Gottfried Wilhelm Leibniz-Prize 2025 goes to Prof. Dr Robert Zeiser for his outstanding research in haematology and immunology. Zeiser’s research at the University of Freiburg and the Medical Center – University of Freiburg have led, among other things, to new types of cancer therapy that has increased survival rates and the patients’ quality of life.https://www.gesundheitsindustrie-bw.de/en/article/press-release/top-german-research-prize-goes-freiburg-cancer-researcher
Expert interview - 16/12/2024 Learning from Nature for Innovation Natural phenomena are used to find technological solutions in a number of fields. In an interview with BIOPRO, Prof. Dr. Peter M. Kunz discusses groundbreaking innovations emerging from Baden-Württemberg and shares insights on how the principles of bionics can inspire the next generation of innovators.https://www.gesundheitsindustrie-bw.de/en/article/news/learning-nature-innovation
Press release - 09/12/2024 Brain tumour cells rapidly integrate into brain-wide neuronal circuits Researchers at the Medical Faculty of Heidelberg University and the Heidelberg University Hospital have used modified rabies viruses to label glioblastoma tumour cells and their direct cell contacts in the mouse brain. The new method showed that the tumour cells are connected to different types of nerve cells throughout the entire brain at a very early stage of the disease. https://www.gesundheitsindustrie-bw.de/en/article/press-release/brain-tumour-cells-rapidly-integrate-brain-wide-neuronal-circuits
UKCA product marking - 18/12/2024 New medical device marking requirements and regulations in Great Britain Since Brexit, additional regulations for medical devices have come into effect in Great Britain, i.e. England, Wales and Scotland. Although the transition periods have been extended, medical device manufacturers should familiarise themselves with the new conformity marking requirements. EU medical device regulations will continue to apply in Northern Ireland.https://www.gesundheitsindustrie-bw.de/en/article/news/new-medical-device-marking-requirements-and-regulations-great-britain
Event - 09/04/2025 - 10/04/2025 German Biotech Days 2025 Heidelberg, Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/deutsche-biotechnologietage-2025